Christian Herzog

Christian Herzog

Auto-generated profile, based on publicly available information

Christian Herzog

Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, Arkansas

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2006 in Protein Science
Verified
Journal Article
Open access
PDF file
RMRoger A. Moore
Roger A. Moore
CHChristian Herzog
Christian Herzog
JEJohn Errett
John Errett
DKDavid A. Kocisko
David A. Kocisko
KAKevin M. Arnold
Kevin M. Arnold
SPSuzette A. Priola
Suzette A. Priola
A central feature of transmissible spongiform encephalopathies (TSE or prion diseases) involves the conversion of a normal, protease‐sensitive glycoprotein termed prion protein (PrP‐sen) into a pro‐tease‐resistant form, termed PrP‐res. The N terminus of PrP‐sen has five copies of a repeating eight amino acid sequence (octapeptide repeat). The presence of one to nine extra copies of this motif is associated with a heritable form of Creutzfeld‐Jakob disease (CJD) in humans. An increasing number of octapeptide repeats correlates with earlier CJD onset, suggesting that the rate at which PrP‐sen misfolds into PrP‐res may be influenced by these mutations. In order to determine if octapeptide repeat insertions influence the rate at which PrP‐res is formed, we used a hamster PrP amyloid‐forming peptide (residues 23–144) into which two to 10 extra octapeptide repeats were inserted. The spontaneous formation of protease‐resistant PrP amyloid from these peptides was more rapid in response to an increased number of octapeptide repeats. Furthermore, experiments using full‐length glycosylated hamster PrP‐sen demonstrated that PrP‐res formation also occurred more rapidly from PrP‐sen molecules expressing 10 extra copies of the octapeptide repeat. The rate increase for PrP‐res formation did not appear to be due to any influence of the octapeptide repeat region on PrP structure, but rather to more rapid binding between PrP molecules. Our data from both models support the hypothesis that extra octapeptide repeats in PrP increase the rate at which protease resistant PrP is formed which in turn may affect the rate of disease onset in familial forms of CJD.

1 June 1999 in Journal of Travel Medicine
Verified
Journal Article
Open access
PDF file
NNNipa Naraporn
Nipa Naraporn
PKPakamatz Khawplod
Pakamatz Khawplod
KLKornvika Limsuwan
Kornvika Limsuwan
PTPenmas Thipkong
Penmas Thipkong
CHChristian Herzog
Christian Herzog
HWHenry Wilde
Henry Wilde
Nipa Naraporn, RN, Pakamatz Khawplod, BSc, Kornvika Limsuwan, BSc, Penmas Thipkong, BPharm, Christian Herzog, MD, Reinhard Glueck, PhD, Terapong Tantawichien, M

1 May 2025 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
JHJoseph Holthoff
Joseph Holthoff
NKNithin Karakala
Nithin Karakala
Alexei BasnakianAlexei Basnakian
Alexei Basnakian
RERicky D. Edmondson
Ricky D. Edmondson
TFTodd Wesley Fite
Todd Wesley Fite
JAJohn M. Arthur
John M. Arthur
The ability to predict progression to severe AKI remains an unmet challenge. Early prognostic biomarkers of AKI hold promise to improve patient outcomes by early implementation of clinical therapy, as well as unravel the pathophysiological mechanisms of AKI. Here, we present a novel urinary biomarker, IGFBP-1, that predicts the progression to severe AKI following cardiac surgery. In addition, we show that IGFBP-1 mice are protected against CIAKI, suggesting a mechanistic role for IGFBP-1 in AKI.

18 February 2026 in Laboratory Investigation
Verified
Journal Article
Open access
ASAaron Storey
Aaron Storey
TCTiffany Caza
Tiffany Caza
SHSamar Hassen
Samar Hassen
RERick Edmondson
Rick Edmondson
CHChristian Herzog
Christian Herzog
CLChristopher Larsen
Christopher Larsen
The complement system plays a central role in glomerular disease development and resolution. Currently, renal biopsies assess the presence of complement through limited immunofluorescence stains (C3 and C1q). With >50 total proteins and fragments involved in the complement cascade, this method offers a severely limited view into the mechanisms of tissue injury orchestrated by complement activation. A more comprehensive evaluation of complement components will advance the understanding of complement involvement in glomerular diseases by allowing for multiplex detection of complement cascade proteins and activation products, which can be achieved by mass spectrometry (MS). Data-independent acquisition MS was performed following extraction of proteins from tissue lysates, microdissected glomeruli, or protein G immunoprecipitates from residual kidney biopsy tissue. Cohorts included patients with lupus nephritis, membranous nephropathy and membranous lupus nephritis, diabetic glomerulosclerosis, C3 glomerulonephritis, and control biopsies. Abundances of complement components by MS correlated with immunofluorescence intensity of C1q on kidney biopsies. Increased abundances of complement classical, lectin, final common pathway, and regulatory proteins correlated with disease activity in lupus nephritis. Complement protein abundances of final common pathway components were heterogeneous between patients with the same disease state, including diabetic glomerulosclerosis and various forms of proliferative glomerulonephritis. Finally, complement proteins and their activation products can be mapped to determine which components are impacted among individuals and between disease states. In conclusion, complement proteins and some of their split products can be reliably measured by MS of kidney biopsies, which can enhance our understanding of complement-mediated tissue injury and heterogeneity in glomerular diseases.


16 June 2021 in Aktuelle Ernahrungsmedizin
Verified
Conference Paper
Closed access
CHC Herzog
C Herzog
SLS Lindner
S Lindner
AMA Matijevic
A Matijevic
VWV Wagner
V Wagner
VHV Hacker
V Hacker
BWB Walcher
B Walcher
Introduction Olfactory dysfunction is mostly caused by post upper respiratory tract infections (URTI). This is currently becoming apparent due to the Covid-19 pandemic, with olfactory dysfunction being a common early symptom that affects a significant fraction of people infected by Covid-19. Objectives The objective of this systematic review is to determine evidence on interventions to improve olfactory performance among patients with post-infectious smell disorders and identify implications for those affected by Covid-19 induced olfactory dysfunctions. Methods A systematic search of relevant literature published between January 2010 and November 2020 was conducted in the databases Pubmed, CINAHL, Embase and Cochrane Central Register of Controlled Trials. Further studies were assessed by reference tracking. Results Based on 13 studies included in this review, two types of interventions to improve olfactory function in post-infectious patients were found. Eight studies describing olfactory training interventions showed a significant improvement of TDI Score and/or its subscores odour threshold (T), odour discrimination (D) and odour identification (I). Five studies assessing the effect of olfactory therapy or olfactory therapy combined with olfactory training revealed diverging results with only significant effects on small scale. A negative correlation of disease duration and improvement of olfactory function was found in four trials. Conclusion Results of this review show a promising but limited effect to improve olfactory function in patients with post-infectious olfactory disorder with either olfactory training or olfactory therapy. The work presented encourages to continue researching in this field and raise awareness of this highly topical issue. Disclosure of Interest None declared Publication Date: 16 June 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany